| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
|
Still deciding? Get samples of US$ 100/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name | Eptifibatide |
| CAS | 148031-34-9 |
| MF | C37H53N11O11S2 |
| MW | 831.96 |
| Appearance | White Powder |
| Specific Optical Rotation | -78~-88° |
| Water Content | ≤8.0% |
| Acetate Content | ≤15.0% |
| Amino Acid Composition | ±10% of theoretical |
| Single Impurity | ≤1.0% |
| Peptide Content | ≥80% |
| Bacterial Endotoxins | ≤5EU/mg |
| Purity | ≥98.0% |
Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist,adverse reactions are mild , it can be discontinued immediately while adverse reactions occur . It has Strong effect and high selectivity . It has no antigenicity,and it does not cause allergic reactions. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events. It can limit the non-Q-wave myocardial infarction,and reduce through wall myocardial infarction occurrance.
){kind=link}